Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

News > All

Total search results: 9859 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 16 17 18 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Philogen S.p.A.. (7/20/17). "Press Release: Philogen Enters into Multi-target Research Agreement with Boehringer Ingelheim in the Field of DNA-encoded Chemistry". Siena. 2017-07-20
Philips. (7/20/17). "Press Release: Chief Business Leader of Philips’ Personal Health Businesses Pieter Nota to Leave Company". Amsterdam. 2017-07-20
Ionicon Analytik GmbH. (7/20/17). "Press Release: Ionicon Launches AMC-Monitor T-1000 for the Semiconductor Industry". Innsbruck. 2017-07-20
Basilea Pharmaceutica Ltd.. (7/20/17). "Press Release: Basilea Announces Completion of the License Agreement with Pfizer for Antifungal Cresemba for Europe, Russia, Turkey and Israel". Basel. 2017-07-20
Sartorius AG. (7/19/17). "Press Release: Sartorius Supervisory Board Elects Dr. Lothar Kappich as Its Chairman". Göttingen. 2017-07-19
Novimmune S.A.. (7/18/17). "Press Release: Novimmune and Shire Sign License Agreement Deepening Bispecific Antibody Research Collaboration". Geneva. 2017-07-18
Agilent Technologies Inc.. (7/18/17). "Press Release: Hans E. Bishop to Join Agilent’s Board of Directors. CEO of Juno Therapeutics Brings Deep Knowledge of the Biopharma Industry". Santa Clara, CA. 2017-07-18
Royal Philips. (7/18/17). "Press Release: Philips to Strengthen Its Ultrasound Business with the Acquisition of Clinical Applications and Imaging Software Company TomTec". Amsterdam. 2017-07-18
Humabs BioMed S.A.. (7/18/17). "Press Release: Humabs BioMed and University of California, Berkeley Announce Publication of Data for Novel Antibody-based Assay to Detect Zika Virus Infection". Bellinzona & Berkeley, CA. 2017-07-18
4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. 2017-07-18
Novartis AG. (7/18/17). "Press Release: Q2 Results Confirm Full Year Guidance". Basel. 2017-07-18
Eurofins Scientific. (7/18/17). "Press Release: Eurofins Issues EUR 650m New Euro Bond". 2017-07-18
Autolus Therapeutics Ltd.. (7/18/17). "Press Release: Autolus Announces Senior Leadership Appointments". London. 2017-07-18
BASF SE. (7/17/17). "Press Release: BASF and Kaiima Announce Collaboration to Identify Novel Herbicide Resistance Traits Using the EP Technology Platform". Limburgerhof & Moshav Sharona. 2017-07-17
Eurofins Scientific. (7/17/17). "Press Release: Eurofins Announces the Potential Launch of a New Senior EUR 500m Bond on the Back of Strong M&A Activity". 2017-07-17
VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany". 2017-07-17
Novartis AG. (7/14/17). "Press Release: Novartis Confirms 5 Year Data for First and Only Fully-human IL-17A Inhibitor Cosentyx Reinforcing Sustained Efficacy and Safety Profile in Psoriasis". Basel. 2017-07-14
PreOmics GmbH. (7/14/17). "Press Release: Diagenode and PreOmics Launch New Streamlined Sample Preparation Solution for Proteomic Analyses". Liège, Denville & Martinsried. 2017-07-14
MorphoSys AG. (7/13/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received US FDA Approval for Tremfya (Guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Planegg-Martinsried. 2017-07-13
BASF SE. (7/13/17). "Press Release: BASF Introduces First New Class of Public Health Insecticide for Malaria Prevention in more than 30 Years". Limburgerhof. 2017-07-13
Wilex AG. (7/13/17). "Press Release: Wilex Reports on First Half-year". Munich. 2017-07-13
Johnson & Johnson Inc.. (7/13/17). "Press Release: Janssen Announces U.S. FDA Approval of Tremfya (guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Horsham, PA. 2017-07-13
Novartis AG. (7/13/17). "Press Release: Novartis CAR-T Cell Therapy CTL019 Unanimously (10-0) Recommended for Approval by FDA Advisory Committee to Treat Pediatric, Young Adult r/r B-cell ALL". Basel. 2017-07-13
Epigenomics AG. (7/12/17). "Press Release: Epigenomics AG – Voluntary Public Takeover Offer by Summit Hero Holding Not Successful". Berlin. 2017-07-12
Merck KGaA. (7/12/17). "Press Relase: Merck Refines Western European Life Science Production Site Network". Darmstadt. 2017-07-12
Enterome S.A.. (7/11/17). "Press Release: Enterome and Nestlé Health Sciences Launch New Diagnostics Company". Paris. 2017-07-11
Noxxon Pharma N.V.. (7/11/17). "Press Release: Noxxon Pharma Announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the EuroNext Growth Market". Berlin. 2017-07-11
Creathor Venture Management GmbH. (7/11/17). "Press Release: Creathor Venture Invests in AI-enabled Clinical Genetic Testing Company Blueprint Genetics as Part of an up to EUR 14 Million Financing Round". Bad Homburg v. d. H.. 2017-07-11
Numares AG. (7/11/17). "Press Release: Numares AG Achieves Key Milestone – Identifies Candidate Metabolomic Network for Bladder Cancer Diagnostics". Regensburg. 2017-07-11
Genedata AG. (7/11/17). "Press Release: Genedata Selector Expands Partnership with AB Enzymes". Basel. 2017-07-11
Silence Therapeutics plc. (7/10/17). "Press Release: IP Update". 2017-07-10
CRISPR Therapeutics AG. (7/10/17). "Press Release: CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration". Cambridge, MA & Basel. 2017-07-10
Phenex Pharmaceuticals AG. (7/10/17). "Press Release: Phenex AG Announces Milestone Payment from Janssen for the Entry of RORgt Inhibitor into Phase I". Ludwigshafen. 2017-07-10
Stada Arzneimittel AG. (7/10/17). "Press Release: Stada Supports Renewed Improved Takeover Offer Announced by Bain Capital and Cinven". Bad Vilbel. 2017-07-10
Curetis N.V.. (7/7/17). "Press Release: Curetis to Attend Key Investor and Scientific Conferences in the Third Quarter 2017". Amsterdam & Holzgerlingen. 2017-07-07
Evotec AG. (7/6/17). "Press Release: Evotec Received Funding from IFB Hamburg to Identify Antibody-mediated T-Cell Immunotherapies". Hamburg. 2017-07-06
Epigenomics AG. (7/6/17). "Press Release: Epigenomics AG Issues Change in Guidance for Financial Year 2017". 2017-07-06
4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. 2017-07-06
Evolva Holding S.A.. (7/6/17). "Press Release: Neil Goldsmith Stepping Down as CEO and Board Member of Evolva". 2017-07-06
Oxford BioMedica plc. (7/6/17). "Press Release: Oxford BioMedica Announces a Major Supply Agreement". Oxford. 2017-07-06
Lonza Group Ltd.. (7/6/17). "Press Release: Lonza Completes Acquisition of Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Basel. 2017-07-06
CRISPR Therapeutics AG. (7/5/17). "Press Release: CRISPR Therapeutics to Present at the Piper Jaffray GenomeRx Symposium". Basel & Cambridge, MA. 2017-07-05
Horizon Discovery Group plc. (7/5/17). "Press Release: Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform". Cambridge. 2017-07-05
Seventure Partners. (7/5/17). "Press Release: Health for Life Capital Participates in $13.2m Financing of Japanese Microbiome Leader Anaeropharma Science". Paris. 2017-07-05
Roche Diagnostics GmbH. (7/5/17). "Pressemitteilung: Roche weiht Neubauten des Biotechnologie-Zentrums in Penzberg ein. Investitionen am Roche Standort Penzberg von 600 Millionen Euro". Penzberg. 2017-07-05
Eurofins Scientific. (7/4/17). "Press Release: Eurofins Announces AOAC and AFNOR Certification for BACGene and BACSpec Listeria Kits". 2017-07-04
Noxxon Pharma N.V.. (7/4/17). "Press Release: Noxxon Announces First Patients Treated in Phase I/II Clinical Trial of NOX-A12 Combined with Keytruda in Metastatic Pancreatic and Colorectal Cancer". Berlin. 2017-07-04
Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen. 2017-07-03
Silence Therapeutics plc. (7/3/17). "Press Release: Change of Adviser". 2017-07-03
Silence Therapeutics plc. (7/3/17). "Press Release: Issue of Claim in the UK High Courts". 2017-07-03
Analytik Jena AG. (6/30/17). "Press Release: Analytik Jena Sells AJ Blomesystem". Jena & Cologne. 2017-06-30
Oxford BioMedica plc. (6/30/17). "Press Release: Oxford BioMedica Announces Refinancing of Debt Facility". London. 2017-06-30
mySugr GmbH. (6/30/17). "Press Release: mySugr Joins the Roche family". San Diego, CA. 2017-06-30
iTeos Therapeutics S.A.. (6/29/17). "Press Release: iTeos Therapeutics Appoints Mohamed Ragab, M.D., as Vice President, Corporate Development". Gosselies. 2017-06-29
Arbeitskreis der BioRegionen. (6/28/17). "Press Release: Dr. Hinrich Habeck folgt nach sechs Jahren Dr. Klaus Eichenberg in seinem Amt. Der neue Sprecher des AK BioRegio setzt auf Fortführung des Erfolgskurses". Berlin. 2017-06-28
Evotec AG. (6/28/17). "Press Release: Evotec Expands iPSC Drug Discovery Leadership through Strategic Collaboration with Censo Biotechnologies". Hamburg. 2017-06-28
Cellnovo. (6/28/17). "Press Release: Cellnovo Signs Expanded Agreement to Build Second Production Line with Flex". Paris. 2017-06-28
Cellectis S.A.. (6/28/17). "Press Release: Cellectis Appoints Rainer Boehm, M.D. and Hervé Hoppenot to Board of Directors". New York, NY. 2017-06-28
Indi Molecular. (6/28/17). "Press Release: Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Development". Culver City, CA. 2017-06-28
BioGeneration Ventures B.V.. (6/27/17). "Press Release: BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target". Naarden. 2017-06-27
Selexis S.A.. (6/27/17). "Press Release: Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins". Geneva. 2017-06-27
Miltenyi Biotec GmbH. (6/27/17). "Press Release: Miltenyi Biotec Acquires Sensovation". 2017-06-27
Oculis ehf.. (6/27/17). "Press Release: Eye-drop for Diabetic Retinopathy – Successful Eurostars grant Application". Reykjavik. 2017-06-27
Bruker Corporation. (6/26/17). "Press Release: Bruker Announces Novel NMR Phenomics Research Capabilities". Brisbane. 2017-06-26
CureVac AG. (6/26/17). "Press Release: CureVac Expands GMP Production Capacities for RNA Products". Tübingen. 2017-06-26
EQT Partners. (6/24/17). "Press Release: EQT VII to Invest in Global »Hidden Champion« and Medical Mobility Technology Market Leader Ottobock". 2017-06-24
Tecan Group Ltd.. (6/23/17). "Press Release: DiaSorin and Tecan to Collaborate in New Platform Development". Saluggia & Männedorf. 2017-06-23
Merck KGaA. (6/23/17). "Press Release: Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis". Darmstadt. 2017-06-23
NMI TT Pharmaservices. (6/22/17). "Press Release: NMI TT Pharmaservices and Charité Awarded Grant for Development of Protein Profiling for Individualization of Tumor Therapy". Berlin. 2017-06-22
DiaSorin S.p.A.. (6/22/17). "Press Release: DiaSorin and Qiagen Sign Collaboration to Expand Liaison Test Menu througth Adoption of Select Qiagen Assays". Saluggia, Hilden & Germantown, MD. 2017-06-22
Evotec AG. (6/22/17). "Press Release: »Lab282« Accelerates with Second Round Funding". Hamburg. 2017-06-22
Thermo Fisher Scientific Inc.. (6/22/17). "Press Release: FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies". Carlsbad, CA. 2017-06-22
Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. 2017-06-22
Boehringer Ingelheim. (6/21/17). "Press Release: New Data Reveal High Rates of Stroke History in Asymptomatic Atrial Fibrillation Patients". Ingelheim. 2017-06-21
Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. 2017-06-21
InflaRx GmbH. (6/21/17). "Press Release: InflaRx Promotes Othmar Zenker, M.D. to Newly Created Position of Chief Medical Officer". Jena. 2017-06-21
Shimadzu Europe GmbH. (6/21/17). "Press Release: Shimadzu Has Acquired AlsaChim, a Specialist for High-quality Analytical Isotope Labeled Standards". 2017-06-21
OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. 2017-06-20
Merck KGaA. (6/20/17). "Press Release: Merck Ventures Creates New Immuno-Oncology Company iOnctura". Darmstadt. 2017-06-20
Evotec AG. (6/20/17). "Press Release: Evotec Announces Strategic Investment in Facio Therapies to Support Development of Novel FSHD Therapy". Hamburg. 2017-06-20
Affiris AG. (6/20/17). "Press Release: Vaccine that Lowers Cholesterol in Mice Offers Hope of Immunising against Cardiovascular Disease". 2017-06-20
Debiopharm International SA. (6/20/17). "Press Release: Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor". Craigavon & Lausanne. 2017-06-20
PerkinElmer, Inc.. (6/19/17). "Press Release: PerkinElmer to Acquire Euroimmun for Approximately $1.3 Billion". Waltham, MA. 2017-06-19
CRISPR Therapeutics AG. (6/19/17). "Press Release: CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Basel. 2017-06-19
Gamida Cell Ltd.. (6/19/17). "Press Release: Gamida Cell Announces $40 Million Private Financing". Jerusalem. 2017-06-19
Intellia Therapeutics, Inc.. (6/19/17). "Press Release: Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Cambridge, MA. 2017-06-19
TxCell S.A.. (6/19/17). "Press Release: TxCell Appoints Lentigen Technology, Inc. to Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection". Valbonne. 2017-06-19
Wilex AG. (6/19/17). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates". Munich. 2017-06-19
Novartis AG. (6/19/17). "Press Release: Sandoz Receives Approval in Europe for Rixathon (Biosimilar Rituximab) to Treat Blood Cancers and Immunological Diseases". Holzkirchen. 2017-06-19
G1 Therapeutics, Inc.. (6/17/14). "Press Release: G1 Therapeutics Completes Leadership Team with Appointment of Raj Malik, MD, Chief Medical Officer and Greg Mossinghoff, Chief Business Officer". Research Triangle Park, NC. 2017-06-17
Idorsia Ltd.. (6/16/17). "Press Release: Idorsia – Reaching Out for More. Idorsia Commences Trading on SIX Swiss Exchange (Ticker: IDIA)". Allschwil. 2017-06-16
Actelion Ltd.. (6/16/17). "Press Release: Johnson & Johnson Completes Acquisition of Actelion". Allschwil. 2017-06-16
Oncotec Pharma Produktion GmbH. (6/16/17). "Press Release: Oncotec Celebrates 20 Years of Successful Company History at the Dessau Site". Dessau. 2017-06-16
Helsinn Healthcare S.A.. (6/16/17). "Press Release: Helsinn Investment Fund Leads the Financial Round in GreenBone". Lugano. 2017-06-16
Medicxi Ventures. (6/15/17). "Press Release: Medicxi Launches First $300m Late-stage Life Sciences Fund Medicxi Growth 1 (MG1), Backed by Novartis and Verily". London & Geneva. 2017-06-15
ProBioGen AG. (6/15/17). "Press Release: ProBioGen Grants a License for Human Lymph Node Technology to TissUse for Multi-Organ-Chip Applications". Berlin. 2017-06-15
Merck KGaA. (6/15/17). "Press Release: Merck Expands Distribution Agreement with Public Health England". Darmstadt. 2017-06-15
Biophytis S.A.. (6/15/17). "Press Release: Biophytis Selects SGS Life Science Services to Conduct MACA-PK, Clinical Study of Macuneos in Dry AMD". Paris. 2017-06-15
Human Longevity, Inc.. (6/15/17). "Press Release: Human Longevity, Inc. Announces Agreement with Merck KGaA, Darmstadt, Germany to Engage in Cancer Biomarker Discovery in Advanced Melanoma". San Diego, CA. 2017-06-15
Cellestia Biotech AG. (6/15/17). "Press Release: Cellestia Biotech AG Extends Management Team and Scientific Advisory Board". Basel. 2017-06-15
next pagenext page 1 2 3 ... 16 17 18 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top